Refine your search
Collections
Co-Authors
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Bhaskaran, Renjitha
- Physician Preference of Anti-Diabetic Medications and Complications in Pancreatic Diabetes-An Experience from a Tertiary Care Teaching Hospital
Abstract Views :163 |
PDF Views:0
Authors
Affiliations
1 Department of Pharmacy Practice, Amrita School of Pharmacy, Kochi, Amrita Vishwa Vidyapeetham, AIMS Health Science Campus, Kochi, Kerala, IN
2 Department of Gastroenterology, Amrita Institute of Medical Sciences and Research Centre, Kochi, IN
3 Department of Biostatistics, School of Medicine, Amrita Vishwa Vidyapeetham, Kochi, IN
4 Department of Pharmacy Practice, Amrita School of Pharmacy, Kochi, Amrita Vishwa Vidyapeetham, AIMS Health Science Campus, Kochi, IN
1 Department of Pharmacy Practice, Amrita School of Pharmacy, Kochi, Amrita Vishwa Vidyapeetham, AIMS Health Science Campus, Kochi, Kerala, IN
2 Department of Gastroenterology, Amrita Institute of Medical Sciences and Research Centre, Kochi, IN
3 Department of Biostatistics, School of Medicine, Amrita Vishwa Vidyapeetham, Kochi, IN
4 Department of Pharmacy Practice, Amrita School of Pharmacy, Kochi, Amrita Vishwa Vidyapeetham, AIMS Health Science Campus, Kochi, IN
Source
Research Journal of Pharmacy and Technology, Vol 12, No 3 (2019), Pagination: 1075-1078Abstract
Aim: There are no guidelines for use of diabetic medications in pancreatic diabetes. Hence we attempted to the benefits of antidiabetic agents in pancreatic diabetes. Materials and methods: a total of 670 chronic pancreatitis patients are selected. Out of that about 126 patients with pancreatic diabetic are selected for the study. The data collected from 2010. Results: In this study mean age was found to be 53.86±12.53. The male patients (73.8%) were more predominant in this study than female patients (26.2%). The complications of chronic pancreatitis among 126 patients, 126 (100) patient had diabetes mellitus (DM), 100 (79) patients had pain. Among 126 patients 52 (41.3%) patients had taken insulin only, 21 (16.7%) patients had taken insulin+ oral combination, 16 (12.7%) patients had taken Biguanides, 13 (10.3%) of patients had taken oral combinations, 13 (10.3%) patients had taken alpha glucosidase inhibitors, 11 (8.7%) patients who are taken sulfonyl ureas. Most of the patients took insulin monotherapy. Conclusion: Insulin was most preferred agent. Metformin was the most commonly preferred oral antidiabetic agent.Keywords
Chronic Pancreatitis, Type3c DM, Pancreatic Enzymes, Pseudocyst, Malabsorption.References
- Rajesh G, Veena A B, Menon S, Balakrishnan V. Clinical profile of early onset and late onset idiopathic chronic pancreatitis in india. Indian journal of gastroenterology 2014;33:231-6.
- Wang W, Guo Y, Liao Z, et al. Occurrence of and risk factors for diabetes mellitus in Chinese patients with chronic pancreatitis. Pancreas 2011;40:206-12.
- Malka D, Hammel P, Sauvanet A, et al. Risk factors for diabetes mellitus in chronic pancreatitis. Gastroenterology 2000;119:1324-32.
- Sha, S A Das, A K B Kumar, A G Unnikrishnan, et al. baseline characteristics of the Indian cohort from the improve study: a multinational, observational study of biphasic insulin aspart 30 treatment for type 2 diabetes. Advances in therapy 2009;26:325-35.
- Meier JJ, Butler PC, Saisho Y et al. beta cell replication is the primary mechanism subserving the postnatal expansion of beta cell mass in humans. Diabetes 2008;57:961–73.
- Schrader H, Menge BA, Schneider S, et al. Reduced pancreatic volume and beta-cell area in patients with chronic pancreatitis. Gastroenterology 2009;136:513–22.
- Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology 2013;144:1252-61.
- Bang UC, Benfield T, Hyldstrup L, Bendtsen F, Jensen JB et al. Mortality, cancer, and comorbidities associated with chronic pancreatitis: A Danish Nationwide Matched-cohort study. Gastroenterology 2014;146:989-994.
- Pupelis G, Ptasnuka MV, Novikovs V et al. Surgical management of chronic pancreatitis: on the way to a specialised service in Latvia. J Pancreas 2016;17:637-642.
- Kristiansen L, Gronbaek M, Becker U, Tolstrup JS. Risk of pancreatitis according to alcohol drinking habits: a population based cohort study. Am J Epidemiol 2008;168:932-7
- L frulloni, A. Gabbrielli, R. Pezzilli et al. Chronic pancreatitis: report from a multicenter Italian survey on 893 patients. Dig Liver Dis 2010;42;156.
- V balakrishnan, Topical chronic pancreatitis: An update. Medicine update 2008;18:323-329.
- Singh A and Dwivedi S. Study of adverse drug reactions in patients with diabetes attending a tertiary care hospital in newdelhi, india. Indian J Med Res 2017;145:247-249.
- Adibe M.O. et al. Outpatient utilization of anti-diabetic drugs in the south eastern nigeria. Int J. Drug Dev & Res 2009;1:27-36.
- Agarwal AA, Jadhav PR, Deshmukh YA. Prescribing pattern and efficacy of anti-diabetic drugs in maintaining optimal glycemic levels in diabetic patients. J Basic Clin Pharma 2014;5:79-83.
- Stein SA, Lamos EM, Davis SN. A review of the efficacy and safety of oral antidiabetic drugs. Exper Opin Drug Saf 2013;12:153-175.